FIVEPRÍME PROTEIN MEDICINES FOR LIFE
Dead / Cancelled — Cancelled — Section 8 (as of 31 Jul 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85019223
- Registration number
- 4455289
- Mark type
- Design + words
- Filed
- 21 Apr 2010
- Published for opposition
- 28 Sept 2010
- Registered
- 24 Dec 2013
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 042 — Scientific and technological services: Research and development services for discovery and development of protein therapeutics, prophylactics, diagnostics, and theranostics for the treatment, prevention, palliation, and diagnosis of diseases
Owner
- Five Prime Therapeutics, Inc., South San Francisco, CA, US
- Five Prime Therapeutics, Inc., South San Francisco, CA, US
- Five Prime Therapeutics, Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 31 Jul 2020 — CANCELLED SEC. 8 (6-YR)
- 24 Dec 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Jan 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jan 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Dec 2013 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Nov 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 13 Nov 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Nov 2013 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Nov 2013 — USE AMENDMENT FILED
- 05 Nov 2013 — TEAS STATEMENT OF USE RECEIVED
- 22 May 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2013 — SOU EXTENSION 5 GRANTED
- 24 Apr 2013 — SOU EXTENSION 5 FILED
- 21 May 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL